Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

@article{Mcomish1993DetectionOT,
  title={Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities},
  author={F. Mcomish and S. Chan and B. Dow and J. Gillon and W. D. Frame and R. Crawford and P. Yap and E. Follett and P. Simmonds},
  journal={Transfusion},
  year={1993},
  volume={33}
}
The serologic reactivity and epidemiology associated with different hepatitis C virus (HCV) variants were investigated in a cohort of 113 anti‐HCV‐positive donors. In Scotland, HCV type 1 accounted for one‐ half of all infections; 40 percent of subjects were infected with HCV type 3, and the remainder were infected with type 2. Reactivity with the NS‐4‐encoded antigens in the first‐generation anti‐c100 assay was absent in 68 percent of donors infected with types 2 and 3, as compared with 10… Expand
Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus
TLDR
Differences in serological reactivity between genotypes indicate that a large proportion of epitopes of the type 1a or 1b recombinant proteins used in current assays are genotype specific. Expand
Hepatitis C virus infection in an HIV‐positive population in normandy: Antibodies, HCV RNA and genotype prevalence
TLDR
The prevalence and the characteristics of hepatitis C virus infection in 161 HIV‐positive patients were studied and all sera were positive for antibodies to the c33 protein and five genotypes and subtypes of the HCV virus were detected. Expand
Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donors
TLDR
Among the sampled population, an HCV prevalence rate of 0.26 percent was found, with the five most common European genotypes causing the infections, and links with age, sex, and ethnic origin emerged. Expand
Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease.
TLDR
The heterogeneous pattern ofHCV genotype distribution in this cohort of patients and the observed relationship between the severity of the related liver disease and specific HCV genotypes may have important implications with respect to the natural history and treatment of HCV-related chronic liver disease in infected hemophiliacs worldwide. Expand
Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second‐generation recombinant immunoblot assay
TLDR
Based on relatively high prevalence of chronic hepatitis in apparently healthy subjects with stable indeterminate RIBA‐2 pattern and HCV RNA positivity should be considered for liver biopsy independently of ALT profile. Expand
Hepatitis C virus (HCV) core serotypes in chronic HCV infection
TLDR
HCV core serologic typing is a simple, inexpensive, and highly reproducible assay that can be applied to more than 50% of viremic HCV antibody carriers prior to the use of more sophisticated molecular typing techniques, and may be helpful in tracking transmissions routes. Expand
Hepatitis C virus genotypes: An investigation of type‐specific differences in geographic origin and disease
TLDR
The data suggest significant geographic clustering of type 4 disease in the Middle East area and poor response to interferon‐α was noted in patients with type 1 disease, which may have important clinical implications. Expand
Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi‐institution analysis
TLDR
SG‐1 HCV was found to predominate in Japan, and the HCV genotypes were found to be related to the stage of hepatitis C disease. Expand
Clinical significance of hepatitis C antibodies in blood donors
TLDR
It is concluded that HCV antibodies found coincidentally in Finnish donors seldom indicates severe liver disease. Expand
HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile
TLDR
Genotype 3a was correlated to IVDU or tattooing as parenteral risk factors for the acquisition of HCV infection, and genotype 2b to prior blood transfusion, and donors with genotypes 1a seemed to have less severe liver disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non‐virus inactivated factor VIII and IX concentrates
TLDR
Comparison of anti‐C‐100 versus second generation tests in immunocompetent drug users revealed a false negative rate of 20% using C‐100 alone, indicating the advantage of using second generation assays for detection of past or current HCV infection. Expand
Patterns of serological markers in transfusion‐transmitted hepatitis C virus infection using second‐generation HCV assays
TLDR
It is concluded that combined application of anti‐HCV immunoblot techniques and cDNA‐PCR in consecutive samples is necessary for reliable diagnosis of either ongoing productive or resolving HCV infection. Expand
Risk factors in hepatitis C virus‐infected blood donors
TLDR
The prevalence of confirmed HCV infection among Amsterdam blood donors is calculated at 0.04 percent; parenteral exposure appears to be the major risk factor forHCV infection. Expand
Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.
TLDR
The detection of anti-HCV in donors who have neither an elevation of alanine aminotransferase level nor presence of antibody to hepatitis B core antigen suggests that donor screening for anti- HCV will further reduce the risk of transfusion-associated hepatitis. Expand
Analysis of genomic variability of hepatitis C virus.
TLDR
Comparisons of sequences of donors and involved recipients determined in isolates prepared from blood samples four years after transfusion revealed that viral RNA sequences are strongly conserved in the NS3 region, indicating that the observed differences in anti-HCV immune response patterns between recipients are more a reflection of their immune reactivity than of divergence of viral strains. Expand
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
TLDR
The screening of blood donors for anti- HCV antibody should prevent about half the cases of transfusion-associated hepatitis, but the donors with infectious virus who are anti-HCV-negative may remain seronegative for prolonged periods. Expand
Prevalence of antibody to hepatitis C virus in a blood donor population
TLDR
For blood donors, the anti‐HCV test correlates with the surrogate tests for non‐A, non‐B hepatitis (anti‐HBc and ALT); however, most anti‐ HCV‐reactive units remain undetected by surrogate tests, so that implementation of anti-HCV screening should further reduce the transmission of HCV via transfusion. Expand
Hepatitis C Viraemia in United Kingdom Blood Donors: A Multicentre Study
TLDR
While first generation anti‐HCV screening assays generate a high proportion of false reactions when screening low prevalence populations, results of the RIBA‐2 confirmatory test correlate well with PCR findings and thus indirectly with both hepatitis C viraemia and infectivity. Expand
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.
TLDR
Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses. Expand
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay
TLDR
The new 4-RIBA represents a candidate confirmation test to discriminate between infective and non-infective HCV C-100 ELISA-positive blood donors. Expand
...
1
2
3
4
5
...